Company / PP&E (Net)
ORAMED PHARMACEUTICALS INC. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$586.0K
FY2025
5-year range
$397.0K / $873.0K
FY2021-FY2025
Trend
-16.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 10 years, ranging from $16,000 in FY2016 to $873,000 in FY2023.
Based on SEC 10-K filings.
$586,000 in FY2025 with a 5-year CAGR of +42.7%.
Declined from $873,000 to $586,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -10.4%
- 5-Year CAGR
- +42.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +42.7%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 16.0% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $586.0K | -16.0% |
| FY2024 | $698.0K | -20.0% |
| FY2023 | $873.0K | +7.1% |
| FY2022 | $815.0K | +105.3% |
| FY2021 | $397.0K | +301.0% |
| FY2020 | $99.0K | +312.5% |
| FY2019 | $24.0K | +41.2% |
| FY2018 | $17.0K | -5.6% |
| FY2017 | $18.0K | +12.5% |
| FY2016 | $16.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026